| P50 | author | Haitao Wang | Q83755254 |
| | Thilini Thrimawithana | Q85368007 |
| | Peter J Little | Q48286305 |
| P2093 | author name string | Zhong-Ping Feng | |
| | Rikang Wang | |
| | Wenhua Zheng | |
| | Jiangping Xu | |
| P2860 | cites work | Effects of nerve growth factor on neuronal plasticity of the kitten visual cortex | Q48297598 |
| | Neural stem cells enhance nerve regeneration after sciatic nerve injury in rats. | Q48437401 |
| | Nerve growth factor induced modification of presynaptic elements in adult visual cortex in vivo | Q48920990 |
| | The protective effect of sonic hedgehog is mediated by the phosphoinositide [corrected] 3-kinase/AKT/Bcl-2 pathway in cultured rat astrocytes under oxidative stress | Q50250439 |
| | A conditional knockout resource for the genome-wide study of mouse gene function | Q21735918 |
| | Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling | Q24296451 |
| | Differential effects of myocilin and optineurin, two glaucoma genes, on neurite outgrowth | Q24329037 |
| | Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors | Q24338527 |
| | The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA | Q24655928 |
| | Nerve growth factor signaling, neuroprotection, and neural repair | Q27919616 |
| | Regulation of cell survival by secreted proneurotrophins | Q27919620 |
| | NGF stimulates extensive neurite outgrowth from implanted dorsal root ganglion neurons following transplantation into the adult rat inner ear. | Q50475435 |
| | Transplantation of NGF-gene-modified bone marrow stromal cells into a rat model of Alzheimer' disease. | Q50654338 |
| | Nerve growth factor collaborates with myocyte-derived factors to promote development of presynaptic sites in cultured sympathetic neurons. | Q52170479 |
| | Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork. | Q54514331 |
| | p75-deficient embryonic dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to NGF | Q71845313 |
| | Ranking of optic disc variables for detection of glaucomatous optic nerve damage | Q73876330 |
| | Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo | Q80344531 |
| | Src and FAK are key early signalling intermediates required for neurite growth in NGF-responsive adult DRG neurons | Q81593501 |
| | Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma | Q84144841 |
| | Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application | Q46306787 |
| | Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma | Q46408620 |
| | Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis | Q46433077 |
| | Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways. | Q46470843 |
| | Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease | Q47695139 |
| | p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor | Q48144985 |
| | Functionally antagonistic interactions between the TrkA and p75 neurotrophin receptors regulate sympathetic neuron growth and target innervation | Q48181185 |
| | Molecular evolution of the neurotrophin family members and their Trk receptors. | Q48231589 |
| | Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes | Q35577282 |
| | Neurotrophic regulation of retinal ganglion cell synaptic connectivity: from axons and dendrites to synapses | Q35959776 |
| | Role of JNK activation in apoptosis: a double-edged sword | Q36027363 |
| | Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients | Q36072790 |
| | Cholinergic abnormalities, endosomal alterations and up-regulation of nerve growth factor signaling in Niemann-Pick type C disease | Q36092402 |
| | Novel and known MYOC exon 3 mutations in an admixed Peruvian primary open-angle glaucoma population | Q36145931 |
| | A novel MYOC heterozygous mutation identified in a Chinese Uygur pedigree with primary open-angle glaucoma. | Q36146045 |
| | Nerve growth factor-independent neuronal survival: a role for NO donors | Q36208432 |
| | PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma | Q36375834 |
| | N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence | Q36512298 |
| | Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma. | Q36581246 |
| | VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma | Q36715908 |
| | Tissue localization of nerve growth factor and nerve growth factor receptors | Q37179161 |
| | Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes | Q37265766 |
| | Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma | Q37304132 |
| | The cholinergic system, nerve growth factor and the cytoskeleton. | Q37695362 |
| | Transforming growth factor-β in normal nociceptive processing and pathological pain models | Q37962474 |
| | Recent preclinical evidence advancing cell therapy for Alzheimer's disease. | Q38024220 |
| | The possible role of the Akt signaling pathway in schizophrenia. | Q38024577 |
| | Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis | Q38039856 |
| | GDNF, NGF and BDNF as therapeutic options for neurodegeneration. | Q38076581 |
| | Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study. | Q38398163 |
| | Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation | Q38461332 |
| | Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery | Q39338594 |
| | Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1). | Q39674464 |
| | Comparison of expression profile of neurotrophins and their receptors in primary and transformed rat retinal ganglion cells. | Q40097792 |
| | Neurotrophins live or let die: does p75NTR decide? | Q41366415 |
| | High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. | Q41481526 |
| | Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis | Q41644952 |
| | Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympatheti | Q42449110 |
| | Effects of nerve growth factor (NGF), fluoxetine, and amitriptyline on gene expression profiles in rat brain | Q42728159 |
| | The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins | Q42795990 |
| | FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling | Q42816513 |
| | PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. | Q42976970 |
| | Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice. | Q43150896 |
| | Alzheimer's Therapeutics: Neurotrophin Domain Small Molecule Mimetics | Q43477496 |
| | Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade | Q44061969 |
| | Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons | Q44072142 |
| | Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension | Q44747101 |
| | Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells | Q44794856 |
| | A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease | Q45883058 |
| | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | Q27919621 |
| | Nerve growth factor levels and mast cell distribution in human coronary atherosclerosis | Q28203216 |
| | Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor | Q28209950 |
| | Adult-onset primary open-angle glaucoma caused by mutations in optineurin | Q28217964 |
| | Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes | Q28254845 |
| | Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. | Q28368422 |
| | Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells | Q28567866 |
| | Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons | Q28568388 |
| | The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells | Q28570801 |
| | The neurotrophin receptor p75NTR as a positive modulator of myelination | Q28572739 |
| | Interaction between two glaucoma genes, optineurin and myocilin | Q28573610 |
| | Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75NTR Activity Is Neurotoxic through a Paracrine Mechanism | Q28584166 |
| | Frs2α enhances fibroblast growth factor-mediated survival and differentiation in lens development | Q28591710 |
| | Axon degeneration: Molecular mechanisms of a self-destruction pathway | Q29013985 |
| | NGF is essential for hippocampal plasticity and learning | Q30491147 |
| | Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses | Q30525529 |
| | Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location | Q30534999 |
| | Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice | Q33180485 |
| | Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways | Q33981022 |
| | Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration | Q33982246 |
| | Topography of neuron loss in the retinal ganglion cell layer in human glaucoma | Q34004263 |
| | Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function | Q34012751 |
| | Glaucoma: genes, phenotypes, and new directions for therapy | Q34090204 |
| | Myocilin and optineurin coding variants in Hispanics of Mexican descent with POAG. | Q34259450 |
| | Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? | Q34286983 |
| | Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease | Q34287016 |
| | The nerve growth factor and the neuroscience chess board | Q34287022 |
| | NGF and the treatment of Alzheimer's disease | Q34347795 |
| | The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death | Q34457074 |
| | Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. | Q34464521 |
| | Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma | Q34470829 |
| | Growth factor delivery-based tissue engineering: general approaches and a review of recent developments | Q34548765 |
| | Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force | Q34591030 |
| | Protective effects of resveratrol in experimental retinal detachment | Q34990639 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glaucoma | Q159701 |
| | peptide | Q172847 |
| | targeted therapy | Q492646 |
| | signal transduction | Q828130 |
| | nerve tissue protein | Q6996861 |
| | pharmaceutical preparation | Q66089252 |
| | nerve growth factors | Q98072643 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 759473 | |
| P577 | publication date | 2014-08-31 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | The nerve growth factor signaling and its potential as therapeutic target for glaucoma | |
| P478 | volume | 2014 | |